Long before germ theory existed, people noticed that silver kept water sweeter and food from spoiling as quickly. That observation was not superstition; it reflects a real physical property of the metal that scientists can now describe at the molecular level. This article traces silver's use as an antimicrobial material from antiquity through modern wound care, explains what is actually known about how it works, is honest about where the clinical evidence is strong and where it is thin, and places the natural polymer chitosan alongside it as a second material with genuinely complementary properties. None of what follows should be read as advice to treat, cure, or prevent any disease; it is a survey of the underlying science and of hygiene as a practice, offered so readers can have an informed conversation with their own physician.
Ancient Vessels and Instinctive Wisdom
Phoenician traders and Greek and Roman households stored water and wine in silver vessels, and travelers reportedly dropped silver coins into water jugs before long journeys. Persian royalty is said to have transported drinking water in silver flasks. American pioneer families are often credited with placing a silver dollar in a milk jug to slow spoilage; this is a well-known piece of folk practice, and while its documentation is more anecdotal than experimental, it fits a pattern seen across cultures long before anyone understood microbiology. People were, in effect, doing empirical trial and error over centuries and settling on a material that reliably kept water and food usable a little longer. It is a modest but genuine example of accumulated human observation converging with what later chemistry would confirm: silver, in contact with water, releases a small but steady concentration of ions that many microorganisms cannot tolerate.
The Oligodynamic Effect: How Silver Ions Act on Microbes
The term for this property is the "oligodynamic effect," first described formally by the Swiss botanist Carl von Nägeli in the 1890s, who observed that trace amounts of metal ions, silver among them, were toxic to algae and bacteria in water even at very low concentrations. Modern laboratory research, largely in vitro, has clarified several mechanisms by which silver ions (Ag+) interfere with microbial cells: they bind to sulfur- and nitrogen-containing groups in bacterial enzymes and structural proteins, disrupting normal cell function; they interact with the bacterial cell membrane, increasing its permeability; and they can generate reactive oxygen species that damage cellular components, including DNA. This multi-target action is one reason silver has historically been considered less prone to the kind of single-mechanism resistance seen with some antibiotics, though laboratory studies have documented bacterial strains that develop reduced susceptibility to silver, so it is not accurate to describe silver resistance as impossible.
From Credé's Drops to the Burn Ward
Silver's transition into formal medicine is well documented. In 1881, the German obstetrician Carl Credé introduced the routine instillation of dilute silver nitrate drops into the eyes of newborns to reduce a serious eye infection acquired during birth, a practice known as Credé's prophylaxis that was adopted widely across Europe and North America and is credited with a substantial reduction in a once-common cause of infant blindness, before antibiotic drops eventually became the more common approach. In the 1960s, Dr. Charles Fox at Columbia University developed silver sulfadiazine cream, which became a mainstay of burn unit care for decades and remains in use in many settings today, generally as a prescription product rather than an over-the-counter item. Its long clinical history demonstrates that topical silver compounds can be formulated, standardized, and studied to a pharmaceutical standard when the intended use is treatment of a diagnosed wound, under a physician's direction.
What Modern Wound-Care Research Actually Shows
It would be dishonest to present silver's modern medical record as uniformly triumphant, and a careful reviewer should not do so. Silver-containing dressings became widespread in wound clinics from the 1990s onward, and a substantial body of research has since examined whether they actually improve outcomes compared with standard, non-silver dressings. A Cochrane systematic review of topical silver for preventing wound infection, first published around 2010 and updated since, concluded that the evidence available was insufficient to establish that silver-containing dressings or agents reliably prevent wound infection or speed healing compared with non-silver alternatives; many of the included trials were small or methodologically limited. Separately, a Cochrane review of dressings for burns found that silver sulfadiazine was, in some comparisons, associated with slower healing than certain modern biosynthetic or other dressings, a finding that surprised many clinicians who had assumed silver's antimicrobial action would translate directly into faster recovery. None of this means silver has no antimicrobial effect in vitro, where it demonstrably does; it means that the leap from "kills bacteria in a petri dish" to "measurably improves human wound healing" is a harder one than early enthusiasm assumed, and it is a leap that should be judged trial by trial rather than by reputation.
Chitosan: A Second Natural Material with a Complementary Role
Alongside silver, another naturally derived material has earned a serious place in modern wound and skin care research: chitosan, a polysaccharide obtained by processing chitin, the structural material found in the shells of shrimp and crab and in the cell walls of certain fungi. Chitosan carries a positive charge under normal skin and wound conditions, which allows it to interact with the negatively charged surfaces of many bacterial cell membranes, disrupting their integrity. It also has genuine hemostatic (blood-clotting-promoting) properties, which is why chitosan-based dressings have been adopted by military and civilian trauma services since the early 2000s to help control bleeding from significant wounds, a use supported by both laboratory and field data. Separately, chitosan forms a flexible film on skin that can help retain moisture, a property of interest in general skin care formulation quite apart from any antimicrobial claim. That two effective materials, silver and chitosan, both trace back to ordinary substances found in seawater, soil, and shell, is a small but genuine illustration of how much practical benefit has been built into the natural world; it is a pattern worth noticing rather than a coincidence to explain away.
Chelation, Formulation, and Sensible Caution
In modern topical products, silver is rarely used as loose metallic powder. It is more commonly formulated as a salt, a nanoparticle suspension, or a chelated compound, in which silver ions are bound to a carrier molecule that stabilizes them and helps control how quickly they are released onto the skin surface. This is a matter of material chemistry, not medicine: chelation is a formulation strategy used across many industries to keep an active ion available in a controlled, stable form rather than an unbound, unpredictable one. A topical product combining chelated silver with chitosan is, from a materials standpoint, pairing an ionic metal with a cationic natural polymer within a skin-care formulation, and consumers are right to want to understand that chemistry rather than take marketing language on faith.
Caution is warranted on one specific point: chronic, excessive exposure to silver, particularly repeated ingestion of colloidal silver products, can cause argyria, a permanent bluish-gray discoloration of the skin caused by silver deposits. It is not generally organ-toxic at the doses involved in documented cases, but it is irreversible and cosmetically significant, and it has been documented in case reports over many decades. This is a reasonable argument for using any silver-containing product as directed, for topical use to remain topical, and for patients with specific skin conditions or on other treatments to raise the product with their own physician before regular use. That is simply informed consent in practice: understanding a material well enough to make a sound decision about it, in partnership with a doctor who knows your history, rather than deferring blindly to either a marketing claim or a blanket institutional dismissal.
None of this history changes the basic hygiene practices that matter most: regular handwashing with soap and water, keeping skin clean and dry, and prompt attention to any wound that shows signs of worsening. Topical products made from silver and chitosan are best understood as tools that fit within that broader framework of personal hygiene and skin care, not substitutes for sound medical judgment when an actual infection is suspected.
Key takeaway: Silver has a genuinely long and scientifically explainable history as an antimicrobial material, but the strength of evidence varies by use, and any topical silver or chitosan product should be understood as part of routine hygiene and skin care rather than as a treatment for disease.